Table 1 Baseline characteristics in PCOS patients with new-onset type 2 diabetes

N

21

21

21

N/A

Age, years

30 ± 5

29 ± 5

28 ± 3

0.131

Weight, kg

70.4 (63.7–77.1)

69.3 (64.6–74.1)

67.9 (63.6–72.2)

0.886

BMI, kg/m²

27.2 (24.94–29.46)

26.38 (24.66–28.1)

26.4 (24.63–28.18)

0.904

WC, cm

86.8 (81.2–92.4)

84.7 (80.0–89.4)

82.8 (79.0–86.6)

0.395

WHR

0.88 ± 0.08

0.86 ± 0.06

0.85 ± 0.06

0.256

FAT%

36.13 (32.74–39.53)

35.12 (32.19–38.05)

33.6 (31.21–35.98)

0.397

FBG, mmol/L

5.63 (5.31–5.96)

5.84 (5.62–6.06)

5.62 (5.39–5.84)

0.166

2hBG, mmol/L

14.73 (13.49–15.97)

15.59 (14.26–16.92)

14.64 (13.66–15.62)

0.482

FINS, μIU/mL

15.78 ± 6.7

16.18 ± 5.3

14.34 ± 4.85

0.546

2hINS, μIU/mL

100.24 (80.63–119.85)

111.82 (92.73–130.91)

100.26 (84.59–115.94)

0.298

HbA1c, %

7.4 ± 0.3

7.4 ± 0.3

7.3 ± 0.2

0.668

AUC glucose

16.63 (15.65–17.62)

17.18 (16.16–18.21)

16.5 (15.81–17.19)

0.586

AUC insulin

129.93 (105.47–154.39)

148.2 (128–168.41)

122.66 (104.04–141.27)

0.152

TG, mmol/L

1.44 (1.16–1.72)

1.34 (1.19–1.5)

1.32 (1.05–1.59)

0.634

TC, mmol/L

4.51 (4.2–4.81)

4.8 (4.44–5.15)

4.94 (4.57–5.31)

0.175

HDL-C, mmol/L

1.26 (1.16–1.37)

1.24 (1.14–1.35)

1.35 (1.26–1.43)

0.167

LDL-C, mmol/L

3.06 ± 0.7

3.4 ± 0.73

3.32 ± 0.69

0.273

hsCRP, mg/L

3.97 (3.1–4.84)

3.94 (3.09–4.8)

4.02 (3.23–4.8)

0.937

LH, IU/L

14.2 (11.28–17.12)

11.57 (9.76–13.37)

12.53 (10.14–14.92)

0.434

FSH, IU/L

6.51 ± 2.04

6.76 ± 1.44

7.33 ± 2.36

0.393

T, nmol/L

2.64 ± 0.69

2.65 ± 0.67

2.64 ± 0.69

0.999

SHBG, nmol/L

24.72 (17.14–32.29)

30.1 (20.48–39.72)

22.64 (15.73–29.54)

0.382

FTI

15.82 (11.06–20.58)

11.72 (8.36–15.08)

16.91 (11.22–22.6)

0.274